The CKB is a dynamic digital resource for interpreting complex cancer genomic profiles. Join thousands of clinicians and researchers across the globe, saving time and finding valuable information that connects cancer variants to therapies and clinical trials.
Important Message: We are excited to share that CKB is now a part of Genomenon!
Find information at their new site linked here: Somatic Curation (genomenon.com).
*CKB content will be accessible here until November 1st, 2024.
JAX-CKB can help increase clinician confidence in completeness and accuracy of the information related to the patient’s tumor genomic profile.
For translational and clinical researchers, JAX-CKB provides thousands of literature citations, FDA drug labels, and clinical trials relative to a tumor’s genomic mutation or profile, resulting in a clear and up-to-date picture of discoveries and active developments for a variety of biomarkers.
Learn more about CKB methodology, utility, and design from the original CKB publication.
Read more about the mission and value of CKB.
Discover more about the future of knowledgebases in precision oncology.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.